Immune Response to PSF in Idiopathic vs Neuromuscular Scoliosis
Key facts
- Who runs it
- Ambrish Patel
- Where
- Columbus, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 20 people, planned
- Started
- Oct 2026
- Expected to end
- Dec 2029
- Type of study
- Observational, 2 groups
- Treatments tested
- Serum blood samples for serum biomarkers of immune response
- Record updated
- 6 August 2026
Who can take part
- Age
- 0 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Any patient undergoing a posterior spinal fusion, regardless of age (birth to adult)
- any patient with a diagnosis of idiopathic or neuromuscular scoliosis
Who cannot take part
- Patient taking immunomodulators (monoclonal antibodies, chemotherapeutic agents)
- chronic steroid use
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 0 and 99 years old?
Where in United States
- Nationwide Children's HospitalColumbus, United StatesContact: Catherine RothNot yet recruiting
About the trial
What the trial wants to find out
The objective of this study is to evaluate the immune response to posterior spinal fusion (PSF) in patients with neuromuscular scoliosis, comparing patients with idiopathic scoliosis who undergo the same procedure. This will be accomplished using serum biomarkers of immune response. Anecdotally, it appears that patients with neuromuscular scoliosis have more fluid resuscitation needs compared to patients with idiopathic scoliosis. The proposed hypothesis of this observation is that patients with neuromuscular scoliosis have a more profound immune response compared to patients with idiopathic scoliosis, which leads to a more robust systematic inflammatory response syndrome.
The 2 groups in the trial
- Neuromuscular scoliosis
Patients with neuromuscular scoliosis undergoing posterior spinal fusion
Treatment: Serum blood samples for serum biomarkers of immune response
- Idiopathic scoliosis
Patients with idiopathic scoliosis undergoing posterior spinal fusion
Treatment: Serum blood samples for serum biomarkers of immune response
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison of Immune Response Following Posterior Spinal Fusion in Patients With Idiopathic vs. Neuromuscular Scoliosis
- Criteria questions
- Built from NCT07734467, who can take part
- Record updated
- 6 August 2026